Pasithea Therapeutics (KTTA) Non-Current Assets (2021 - 2024)
Historic Non-Current Assets for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $8.9 million.
- Pasithea Therapeutics' Non-Current Assets fell 1039.31% to $8.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $36.5 million, marking a year-over-year decrease of 1311.84%. This contributed to the annual value of $9.4 million for FY2023, which is 1511.87% down from last year.
- Latest data reveals that Pasithea Therapeutics reported Non-Current Assets of $8.9 million as of Q3 2024, which was down 1039.31% from $9.0 million recorded in Q2 2024.
- In the past 5 years, Pasithea Therapeutics' Non-Current Assets registered a high of $11.1 million during Q4 2022, and its lowest value of $8570.0 during Q3 2021.
- In the last 4 years, Pasithea Therapeutics' Non-Current Assets had a median value of $9.0 million in 2024 and averaged $6.8 million.
- In the last 5 years, Pasithea Therapeutics' Non-Current Assets skyrocketed by 5986396.73% in 2022 and then plummeted by 1570.11% in 2024.
- Quarter analysis of 4 years shows Pasithea Therapeutics' Non-Current Assets stood at $20124.0 in 2021, then soared by 55074.9% to $11.1 million in 2022, then decreased by 15.12% to $9.4 million in 2023, then fell by 6.01% to $8.9 million in 2024.
- Its Non-Current Assets was $8.9 million in Q3 2024, compared to $9.0 million in Q2 2024 and $9.2 million in Q1 2024.